Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers. PLoS ONE 2013;8(2):e55831 doi: 10.1371/journal.pone.0055831
Scientific Publications
- PMID: 23418465
- Title: Safety and immunogenicity of DNA and MVA HIV 1 subtype C vaccine prime boost regimens a phase I randomised Trial in HIV uninfected Indian volunteers
- Abstract: A randomized, double-blind, placebo controlled phase I trial.
- Date: 1970-08-20
- Year: 2013
- Journal: PLoS ONE
- PMID Author: Mehendale S, Thakar M, Sahay S, Kumar M, Shete A, Sathyamurthi P, Verma A, Kurle S, Shrotri A, Gilmour J, Goyal R, Dally L, Sayeed E, Zachariah D, Ackland J, Kochhar S, Cox JH, Excler JL, Kumaraswami V, Paranjape R, Ramanathan VD
- PMC Link #: PMC3572184
- IAVI Topics: IAVI Clinical Trial
- IAVI Keywords: IAVI P001
Safety and immunogenicity of DNA and MVA HIV 1 subtype C vaccine prime boost regimens a phase I randomised Trial in HIV uninfected Indian volunteers
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
